← Back to Clinical Trials
Recruiting NCT06092385

NCT06092385 SASL Swiss Cirrhosis Cohort

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06092385
Status Recruiting
Phase
Sponsor University Hospital, Basel, Switzerland
Condition Liver Cirrhosis
Study Type OBSERVATIONAL
Enrollment 3,000 participants
Start Date 2024-06-04
Primary Completion 2033-01

Trial Parameters

Condition Liver Cirrhosis
Sponsor University Hospital, Basel, Switzerland
Study Type OBSERVATIONAL
Phase N/A
Enrollment 3,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-06-04
Completion 2033-01
Interventions
Data collection

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This is a national prospective long-term multicentre observational cohort study following patients with cirrhosis in order to systematically and longitudinally record epidemiological, clinical, histological, psychosocial and patient-reported data and biobank biological material from patients with cirrhosis. The central element of all scientific operation and productivity in the Swiss Cirrhosis Cohort Study (SSCiCoS) is the so-called "nested project" (NP). Based on the evolving large pool of data and biological samples, SSCiCoS investigators use the data pool in order to investigate specific hypotheses and questions.

Eligibility Criteria

Inclusion Criteria: * A) Patients with chronic liver disease and histologically proven cirrhosis * B) Control subjects with no signs of cirrhosis Exclusion Criteria: * Age \<18 years * patients who developed hepatocellular carcinoma (HCC) and/or cholangiocellular carcinoma (CCC)

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology